| MRKR Stock | | | USD 1.53 0.02 1.32% |
Marker Therapeutics financial indicator trend analysis is infinitely more than just investigating Marker Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Marker Therapeutics is a good investment. Please check the relationship between Marker Therapeutics Capital Stock and its Current Deferred Revenue accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marker Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
To learn how to invest in Marker Stock, please use our
How to Invest in Marker Therapeutics guide.
Capital Stock vs Current Deferred Revenue
Capital Stock vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Marker Therapeutics Capital Stock account and
Current Deferred Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Marker Therapeutics' Capital Stock and Current Deferred Revenue is -0.57. Overlapping area represents the amount of variation of Capital Stock that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Marker Therapeutics, assuming nothing else is changed. The correlation between historical values of Marker Therapeutics' Capital Stock and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Stock of Marker Therapeutics are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Capital Stock i.e., Marker Therapeutics' Capital Stock and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | -0.57 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Capital Stock
The total amount of a company's capital funded by shareholders through the issue and subscription of shares.
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from Marker Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Marker Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marker Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
To learn how to invest in Marker Stock, please use our
How to Invest in Marker Therapeutics guide.At this time, Marker Therapeutics'
Tax Provision is relatively stable compared to the past year. As of 02/27/2025,
Enterprise Value is likely to grow to about 27.1
M, while
Selling General Administrative is likely to drop slightly above 5.6
M.
Marker Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Marker Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Marker Therapeutics fundamental ratios Accounts
Additional Tools for Marker Stock Analysis
When running Marker Therapeutics' price analysis, check to
measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.